Korys
Also known as Korys NV
Investment company of Belgium's Colruyt family, based in Halle; invests directly, via PE funds and in listed assets across conscious consumer, energy transition and healthy living.
USEFUL FOR Fund managers raising capital · Founders · Business owners seeking a long-term partner · Co-investors
Investment company of the Colruyt family, based in Halle, Belgium. Distinct from Colruyt Group, the listed retailer that is one of its holdings, and from Virya Energy, the energy holding established by Korys and Colruyt Group to combine their renewable-energy participations.
Family & background
- FAMILY
- Colruyt
- WEALTH ORIGIN
- Retail (Colruyt Group, est. 1928)
- HEADQUARTERS
- Halle, Belgium
- FOUNDED
- 2012
- AUM
- €4B (2025)
Investment approach
- GEOGRAPHY
- EuropeIndia
- STAGES
- Series ASeries BGrowth
- ROUTES
- Companies (own capital) · Funds (as LP)
- STRATEGIES
- Direct investmentsFunds (as LP)Public equities
- LATEST DEAL
- Ona Therapeutics (Series B) · Jun 2026
- INBOUND
- Accepts submissions
Overview
Korys describes itself as the entrepreneurial investment company of the Colruyt family, formally established in 2012 and headquartered in Halle, Belgium, with a team of 30 professionals in Belgium and India. It invests through direct participations, private equity funds and liquid investments (multi-asset and listed equities) in three ecosystems: Conscious Consumer, Energy Transition and Healthy Living. In a January 2025 press release it stated a portfolio of more than €4 billion of sustainable investments built over 20 years, including Colruyt Group, Virya Energy and more than 20 direct participations. For technology companies it looks for European-based start-ups and scale-ups with proven product-market fit, and for consumer companies growing and mature businesses with significant commercial traction. Recent deals include co-leading a €43 million round in Entrix (March 2026) and participating in Ona Therapeutics' $86.6 million Series B (June 2026); in January 2025 it sold Sensorfact to ABB.
Investment thesis
Partners with values-driven entrepreneurs and companies that develop solutions for conscious consumption (alternative proteins, local food, healthy leisure, innovative retail and platforms for sustainable consumption), boost healthy living (prevention, diagnosis and innovative treatments such as green and red biotechnologies) and further enable the energy transition (renewable assets in solar, wind and hydrogen, and enabling technologies).
Holdings & investments (56)
- Colruyt GroupNOTABLEConsumer & E-commerce
- NewpharmaNOTABLEConsumer & E-commerce · Alumni
- Virya EnergyNOTABLEClimate & Energy · Majority stake (acquired from Colruyt Group, 2024)
- EntrixClimate & Energy · since 2026
- Ona TherapeuticsBiotech & Life Sciences · since 2026
- Commit BiologicsBiotech & Life Sciences · since 2025
- Euro CompanyFood & Agriculture · since 2025 · Minority stake
- Pantarein WaterClimate & Energy · since 2025
- Schulp VruchtensappenConsumer & E-commerce · since 2025
- GreenelyClimate & Energy · since 2024
- IFHS Group (Ingrizo and Cima Nutrition)Food & Agriculture · since 2022
- TrunkrsMobility & Logistics · since 2022
- SensorfactClimate & Energy · since 2021 · Acquired (ABB, 2025)
- Spanish onshore wind portfolio (Burgos)Climate & Energy · since 2016 · Alumni
- AcuSurgicalHealthTech · Alumni
- AgendiaHealthTech
- AmpacimonClimate & Energy
- Amphivena TherapeuticsBiotech & Life Sciences · Alumni
- AstriVax TherapeuticsBiotech & Life Sciences
- Aphea.BioFood & Agriculture
- Broken String BiosciencesBiotech & Life Sciences · Alumni
- BiocartisHealthTech · Alumni
- BE-LIFEConsumer & E-commerce
- BluebeeHealthTech · Alumni
- CairdacHealthTech · Alumni
- Cell-EasyBiotech & Life Sciences · Alumni
- CorflowHealthTech · Alumni
- D-drinksConsumer & E-commerce
- EneidaClimate & Energy
- FluvesClimate & Energy
- GEOxyzClimate & Energy
- FoodbagConsumer & E-commerce · Alumni
- GinstbergConsumer & E-commerce
- GenaeHealthTech · Alumni
- GreenbyteClimate & Energy · Alumni
- InscriptaBiotech & Life Sciences · Alumni
- Mablink BioscienceBiotech & Life Sciences · Alumni
- MimetasBiotech & Life Sciences · Alumni
- MRM HealthBiotech & Life Sciences
- ProDigestBiotech & Life Sciences
- PanTeraHealthTech
- MyCartisHealthTech · Alumni
- NovyConsumer & E-commerce · Alumni
- OjahFood & Agriculture
- OntoforceSoftware & SaaS
- OroraTechSpace
- ProtealisFood & Agriculture
- Prothea TechnologiesHealthTech · Alumni
- reMYNDBiotech & Life Sciences
- Sahyadri FarmsFood & Agriculture
- SantosConsumer & E-commerce
- SeqOne GenomicsHealthTech · Alumni
- SitemarkClimate & Energy
- Tara BiosystemsBiotech & Life Sciences · Alumni
- UrbantzMobility & Logistics
- VoltStorageClimate & Energy · Alumni
People
- Dries CrevitsPartner, Direct and Fund Investments · source
- Stefaan VandammePartner, Liquid Investments and Corporate · source
- Hilde Van der StraetenInvestment Director, Conscious Consumer · source
- Frederik BauwensInvestment Director, Energy Transition · source
- Brieuc de HultsInvestment Director, Energy Transition · source
- David DevigneInvestment Director, Life Sciences · source
- Daniel LeuthardtInvestment Director · source
- Jérôme ThomasInvestment Director, Listed Equity · source
- Vincent De SmetSenior Investment Manager, Conscious Consumer · source
- Katti Van OosterwijckSenior Investment Manager, Conscious Consumer · source
- Wouter VerstringeSenior Investment Manager, Conscious Consumer · source
- Quentin DupontSenior Investment Manager · source
- Karel Van CleemputSenior Investment Manager, Energy Transition · source
- Eva Van OvermeireSenior Investment Manager, Life Sciences · source
- Pablo QueriatSenior Investment Manager · source
- Gert RyckmansSenior Investment Manager · source
- Srinivas VobilisettiInvestment Manager · source
- Vincent CaudronInvestment Manager · source
- Emiel MichielsInvestment Manager · source
- Thomas LeclercqInvestment Manager · source
- Swati LakhotiyaInvestment Analyst · source
- François de DeckerInvestment Analyst · source
- Ides VandorpeInvestment Analyst · source
- Matthijs Vanden AuweeleJunior Investment Analyst · source
- Hari SubramanianPartner India · source
- Vincent VlieberghAdvisor · source
- Griet AertsAdvisor · source
- Fabienne Van de KeereSenior Advisor · source
- Tina DeneefSenior Finance Manager · source
Frequently asked questions
Korys is a family holding based in Halle, Belgium, founded in 2012.
Korys invests on behalf of the Colruyt family (Retail (Colruyt Group, est. 1928)).
Korys invests its own capital into companies and in third-party funds as an LP. Its stated asset mix includes direct investments, funds (as lp) and public equities.
Korys invests at Series A, Series B and Growth stages in Consumer & E-commerce, Food & Agriculture, Climate & Energy, HealthTech and Biotech & Life Sciences.
Key people at Korys include Dries Crevits (Partner, Direct and Fund Investments), Stefaan Vandamme (Partner, Liquid Investments and Corporate), Hari Subramanian (Partner India) and Vincent Vliebergh (Advisor).
Korys's holdings and investments include Colruyt Group, Newpharma, Virya Energy, AcuSurgical, Agendia, Ampacimon, Amphivena Therapeutics and AstriVax Therapeutics, among others.
The most recent publicly reported investment by Korys is Ona Therapeutics (Series B), announced in Jun 2026.
Korys states that it accepts submissions through its official contact page.